Current Report · Items 2.02, 7.01, 9.01 · 8-K

SBC Medical Group Holdings Incorporated.

SBCNASDAQEQUITYCurrent

Results of Operations and Financial Condition · Regulation FD Disclosure

Filed May 14, 2026Accepted May 14, 2026, 6:50 AM EDTCIK 1930313Accession 0001193125-26-222720

Company context

SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

Current securities

SBCNASDAQ · EQUITY · Current SBCWWNASDAQ · WARRANT · Current

Historical securities (3)

PTWONASDAQ · EQUITY · Historical · closed Sep 17, 2024 PTWOUNASDAQ · UNIT · Historical · closed Sep 17, 2024 PTWOWNASDAQ · WARRANT · Historical · closed Sep 17, 2024

Recent company filings

Disclosure sections

Items 2.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations

Item 2.02 Results of Operations and Financial Condition. On May 14, 2026, SBC Medical Group Holdings Incorporated (the “Company”), issued a press release announcing its results for the quarter ended March 31, 2026. The press release is attached as Exhibit 99.1 and is incorporated herein by reference. The information furnished under Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.

Item 7.01Item 7.01 - Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Additionally, on May 14, 2026, the Company posted an investor presentation to its website, entitled “1Q 2026 Investor Presentation,” which provides an overview of its business (https://ir.sbc-holdings.com/presentations/). From time to time, the Company uses its website (https://ir.sbc-holdings.com/) to distribute company information and makes available free of charge a variety of information for investors, including its filings with the Securities and Exchange Commission (“SEC”), as soon as reasonably practicable after electronically filing that material with, or furnishing it, to the SEC. The information that the Company posts on its website may be deemed material. Accordingly, investors should monitor the Company’s website, in addition to following its press releases, filings with the SEC, and public conference calls and webcasts. Investors may opt in to automatically receive email alerts and other information about the Company when enrolling their email address by visiting the “Email Alerts” section under the “Resources” tab on its website. The Company does not incorporate the information contained on, or accessible through, its website or related social media channels into this Current Report on Form 8-K. The information furnished under this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.

Filed exhibits (1)

EX-99.1 (by filename) sbc-ex99_1.htm

EX-99.1 2 sbc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SBC Medical Group Holdings Announces First Quarter 2026 Financial Results IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights • Total revenues were $43 million, representing a 9% year-over-year decrease. • Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. • Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.11 for the three months ended March 31, 2026, representing a 48% year-over-year decrease. • EBITDA1, which is calculated by adding depreciation and amortization expense to income from operations was $18 million, representing a 26% year-over-year decrease. EBITDA…

Open exhibit ↗